CGEM Net Income Growth
1.00%TTM
Period ending:
CGEM TTM Net Income YoY %%
382.93%-375.96%
2020-12-312026-06-30
Source: Financial Modeling Prep (FMP). Trailing twelve months (TTM). TTM flows use four complete reported quarters. Growth compares with the corresponding period one year earlier.
CGEM net income growth history
Year-over-year net income growth rate. The available trailing twelve months (ttm) series contains 23 observations from Dec 31, 2020 to Jun 30, 2026.
| Period ending | Net Income Growth |
|---|---|
| 1.0036% | |
| -23.6679% | |
| -31.3628% | |
| -51.0481% | |
| -45.4418% | |
| -35.05% | |
| -9.2849% | |
| 8.0709% | |
| -0.2822% | |
| -302.5218% | |
| -237.7183% | |
| -248.0262% | |
| -225.5242% | |
| 184.2161% | |
| 269.6111% | |
| 271.7892% | |
| 309.4899% | |
| -65.4683% | |
| -26.5855% | |
| -119.1207% | |
| -117.8446% | |
| -124.63% | |
| -150.7698% |
Compare net income growth
Other companies in Health Care. Each page shows its own reporting periods and currency.
- Brightspring Health Services Inc (BTSG) net income growth
- Ensign Group Inc (ENSG) net income growth
- Krystal Biotech Inc (KRYS) net income growth
- Protagonist Therapeutics Inc (PTGX) net income growth
- Tg Therapeutics Inc (TGTX) net income growth
- Healthequity Inc (HQY) net income growth
- Pacs Group Inc (PACS) net income growth
- Alkermes (ALKS) net income growth
Compare all covered stocks by net income growth →
All CGEM financial metrics · CGEM stock overview · How to interpret financial metrics
